Literature DB >> 26518562

Doxorubicin causes transient activation of protein poly(ADP-ribosyl)ation in H9c2 cardiomyocytes.

A S Efremova1, S I Shram2, N F Myasoedov1.   

Abstract

Possible involvement of the system of protein poly(ADP-ribosyl)ation in the mechanisms of cardiotoxicity of doxorubicin, one of the most frequently used anticancer drug, was studied in cultures of cardiomyocytes H9c2. The treatment of H9c2 cells with doxorubicin (1 µM) led to a transient (after 6 h of incubation) increase in the nuclear level of poly(ADP-ribosyl)ated proteins. The observed data indirectly indicate the development of genotoxic stress in the doxorubicin-treated cells, probably caused by the stimulatory effects of doxorubicin and its metabolites on the production of reactive oxygen and nitrogen species.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26518562     DOI: 10.1134/S1607672915050178

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN: 1607-6729            Impact factor:   0.788


  13 in total

Review 1.  Cell lines as in vitro models for drug screening and toxicity studies.

Authors:  David D Allen; Raúl Caviedes; Ana María Cárdenas; Takeshi Shimahara; Juan Segura-Aguilar; Pablo A Caviedes
Journal:  Drug Dev Ind Pharm       Date:  2005-09       Impact factor: 3.225

2.  Differentiation-dependent doxorubicin toxicity on H9c2 cardiomyoblasts.

Authors:  Ana F Branco; Susana F Sampaio; Ana C Moreira; Jon Holy; Kendall B Wallace; Ines Baldeiras; Paulo J Oliveira; Vilma A Sardão
Journal:  Cardiovasc Toxicol       Date:  2012-12       Impact factor: 3.231

Review 3.  On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1.

Authors:  Xin Luo; W Lee Kraus
Journal:  Genes Dev       Date:  2012-03-01       Impact factor: 11.361

Review 4.  Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies.

Authors:  Yanti Octavia; Carlo G Tocchetti; Kathleen L Gabrielson; Stefan Janssens; Harry J Crijns; An L Moens
Journal:  J Mol Cell Cardiol       Date:  2012-03-21       Impact factor: 5.000

5.  Mechanism of specific nuclear transport of adriamycin: the mode of nuclear translocation of adriamycin-proteasome complex.

Authors:  K Kiyomiya; S Matsuo; M Kurebe
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

6.  Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro.

Authors:  Partha Mukhopadhyay; Mohanraj Rajesh; Sándor Bátkai; Yoshihiro Kashiwaya; György Haskó; Lucas Liaudet; Csaba Szabó; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-03-13       Impact factor: 4.733

7.  Poly(ADP-ribose)polymerase-activity of chicken embryo cells exposed to nucleotoxic agents.

Authors:  A Ignatius; M Hund; K Tempel
Journal:  Toxicology       Date:  1992-11-30       Impact factor: 4.221

8.  Doxorubicin-induced suppression of poly(ADP-ribose) polymerase-1 (PARP-1) activity and expression and its implication for PARP inhibitors in clinical trials.

Authors:  Tomasz Zaremba; Huw Thomas; Michael Cole; Elizabeth R Plummer; Nicola J Curtin
Journal:  Cancer Chemother Pharmacol       Date:  2010-05-21       Impact factor: 3.333

Review 9.  Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity.

Authors:  Giorgio Minotti; Pierantonio Menna; Emanuela Salvatorelli; Gaetano Cairo; Luca Gianni
Journal:  Pharmacol Rev       Date:  2004-06       Impact factor: 25.468

10.  PARP-1 is involved in autophagy induced by DNA damage.

Authors:  José Antonio Muñoz-Gámez; José Manuel Rodríguez-Vargas; Rosa Quiles-Pérez; Rocío Aguilar-Quesada; David Martín-Oliva; Gilbert de Murcia; Josiane Menissier de Murcia; Antonio Almendros; Mariano Ruiz de Almodóvar; F Javier Oliver
Journal:  Autophagy       Date:  2009-01-27       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.